Sign In
Buy HSDT
$1.51
-0.120 (-7.36%)
At Close: Jun 23, 2026
NEWTOWN, Pa., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
Helius Medical Technologies' (HSDT) CEO Dane Andreeff on Q2 2021 Results - Earnings Call Transcript
11:04pm, Thursday, 12'th Aug 2021
Helius Medical Technologies' (HSDT) CEO Dane Andreeff on Q2 2021 Results - Earnings Call Transcript
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Lags Revenue Estimates
08:50pm, Thursday, 12'th Aug 2021
Helius Medical Technologies, Inc. (HSDT) delivered earnings and revenue surprises of -68.63% and -21.11%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead fo
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Wednesday, 11'th Aug 2021
NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness,
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians
07:05am, Wednesday, 11'th Aug 2021
NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July
04:05pm, Monday, 12'th Jul 2021
NEWTOWN, Pa., July 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer
07:30am, Thursday, 08'th Jul 2021
NEWTOWN, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics
05:30pm, Wednesday, 07'th Jul 2021
Company Selected to Receive the “Pioneer in Technology Award” Company Selected to Receive the “Pioneer in Technology Award”
Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021
07:30am, Wednesday, 30'th Jun 2021
NEWTOWN, Pa., June 30, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
Helius Medical Technologies, Inc. to Participate in Noble Capital Markets' Virtual Road Show Series
04:05pm, Tuesday, 08'th Jun 2021
NEWTOWN, Pa., June 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM), (“Helius” or the “Company”), a neurotech company focused on neurological wellness, to
Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America
07:05am, Wednesday, 02'nd Jun 2021
NEWTOWN, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, tod
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q1 2021 Results - Earnings Call Transcript
10:43pm, Monday, 17'th May 2021
Helius Medical Technologies, Inc. (HSDT) CEO Dane Andreeff on Q1 2021 Results - Earnings Call Transcript
Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results
04:05pm, Monday, 17'th May 2021
NEWTOWN, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, toda
Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st
08:35am, Thursday, 15'th Apr 2021
NEWTOWN, Pa., April 15, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, to
Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
04:30pm, Wednesday, 07'th Apr 2021
NEWTOWN, Pa., April 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, to
